Trial
NCT04156204
Immunosuppressant Medication Dosed Daily After Kidney Transplant
Early Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Colorado, Denver
Collaborators
—
Condition
Kidney Transplant Rejection
Intervention
Medication Event Monitoring System (MEMS)
Why stopped
Discontinuation of study due to site staffing and resources available to conduct the study
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-12-02